PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 2026Exploratory Research in Clinical and Social Pharmacy0 citationsOpen Access

Class-level drug safety surveillance in hospital practice: A pharmacovigilance analysis of 84 therapeutic subclasses from a South Asian tertiary care center

View Full Paper
AUAbdullah UmerAga Khan UniversityAMAdam Khan MohmandAga Khan UniversityNKNaimal Mouzam KhanAga Khan University

Key Points

  • Establishes baseline risk estimates for therapeutic subclasses in pharmacovigilance environments, highlighting the need for improved safety monitoring.
  • Finds that certain drug classes show disproportionately high-risk profiles, indicating areas for deeper investigation and intervention.
  • Assessment indicates the robustness of the Proportional Reporting Ratio (PRR) and Reporting Odds Ratio (ROR) as tools for drug safety evaluation.
  • Supports the need for enhanced drug safety protocols in developing regions to counteract high-risk drug class effects.

Abstract

This analysis establishes baseline class-level risk estimates in a developing pharmacovigilance environment, identifies disproportionately high-risk drug classes, and supports the robustness of PRR and ROR as complementary screening tools for regional drug safety monitoring.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Umer et al. (2026) studied this question.

synapsesocial.com/papers/69a75f05c6e9836116a2a1behttps://doi.org/10.1016/j.rcsop.2026.100711
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Aclarubicin: contemporary insights into its mechanism of action, toxicity, pharmacokinetics, and clinical standing2024 · 13 citations
  2. 2Under-Reporting of Adverse Drug Reactions2006 · 1,930 citations
  3. 3A Systematic Review of Pharmacovigilance Systems in Developing Countries Using the WHO Pharmacovigilance Indicators2022 · 53 citations
  4. 4Neuromuscular block management: evidence-based principles and practice2023 · 48 citations
  5. 5Infection in Solid-Organ Transplant Recipients2007 · 1,940 citations